Cardio Diagnostics Holdings Stock Performance
| CDIO Stock | USD 1.78 0.06 3.26% |
The firm shows a Beta (market volatility) of 2.85, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardio Diagnostics will likely underperform. At this point, Cardio Diagnostics has a negative expected return of -1.1%. Please make sure to confirm Cardio Diagnostics' potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Cardio Diagnostics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:30 | Last Split Date 2025-05-13 |
1 | Insider Trading | 11/12/2025 |
2 | Acquisition by Lau Stanley K. of 5020 shares of Cardio Diagnostics at 2.49 subject to Rule 16b-3 | 11/28/2025 |
3 | Why Cardio Diagnostics Holdings Inc. stock could be next big winner - July 2025 Weekly Recap Weekly Stock Breakout Alerts - | 12/19/2025 |
4 | Analysts Backtest Strategies on Monotype India Limited With Promising Results - Low Risk Investment Ideas Market Trend Real-Time Reports - bollywoodhelpline.com | 12/29/2025 |
5 | Acquisition by Burton Paul Frederick of 2306 shares of Cardio Diagnostics at 2.71 subject to Rule 16b-3 | 12/31/2025 |
6 | Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community | 01/06/2026 |
7 | Cardio Diagnostics Bets On India To Scale AI Heart Diagnostics | 01/08/2026 |
8 | Cardio Diagnostics Holdings, Inc. Short Interest Update | 01/28/2026 |
| Begin Period Cash Flow | 1.3 M | |
| Total Cashflows From Investing Activities | -404.2 K |
Cardio Diagnostics Relative Risk vs. Return Landscape
If you would invest 404.00 in Cardio Diagnostics Holdings on October 31, 2025 and sell it today you would lose (226.00) from holding Cardio Diagnostics Holdings or give up 55.94% of portfolio value over 90 days. Cardio Diagnostics Holdings is currently does not generate positive expected returns and assumes 7.3085% risk (volatility on return distribution) over the 90 days horizon. In different words, 65% of stocks are less volatile than Cardio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardio Diagnostics Target Price Odds to finish over Current Price
The tendency of Cardio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.78 | 90 days | 1.78 | over 95.57 |
Based on a normal probability distribution, the odds of Cardio Diagnostics to move above the current price in 90 days from now is over 95.57 (This Cardio Diagnostics Holdings probability density function shows the probability of Cardio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.85 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cardio Diagnostics will likely underperform. Additionally Cardio Diagnostics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Cardio Diagnostics Price Density |
| Price |
Predictive Modules for Cardio Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardio Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cardio Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardio Diagnostics is not an exception. The market had few large corrections towards the Cardio Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardio Diagnostics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardio Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.16 | |
β | Beta against Dow Jones | 2.85 | |
σ | Overall volatility | 0.74 | |
Ir | Information ratio | -0.15 |
Cardio Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardio Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardio Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardio Diagnostics generated a negative expected return over the last 90 days | |
| Cardio Diagnostics has high historical volatility and very poor performance | |
| Cardio Diagnostics may become a speculative penny stock | |
| Cardio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.89 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 15.78 K. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (4.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from newswire.com: Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to 38 Million |
Cardio Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardio Stock often depends not only on the future outlook of the current and potential Cardio Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardio Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.9 M | |
| Cash And Short Term Investments | 7.8 M |
Cardio Diagnostics Fundamentals Growth
Cardio Stock prices reflect investors' perceptions of the future prospects and financial health of Cardio Diagnostics, and Cardio Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardio Stock performance.
| Return On Equity | -1.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (599.51) % | ||||
| Current Valuation | (2.51 M) | ||||
| Shares Outstanding | 1.83 M | ||||
| Price To Book | 0.41 X | ||||
| Price To Sales | 205.95 X | ||||
| Revenue | 34.89 K | ||||
| Gross Profit | 15.78 K | ||||
| EBITDA | (8.09 M) | ||||
| Net Income | (8.38 M) | ||||
| Cash And Equivalents | 9.66 M | ||||
| Cash Per Share | 5.08 X | ||||
| Total Debt | 969.86 K | ||||
| Current Ratio | 18.42 X | ||||
| Book Value Per Share | 4.61 X | ||||
| Cash Flow From Operations | (4.99 M) | ||||
| Earnings Per Share | (11.91) X | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 10.62 M | ||||
| Retained Earnings | (22.75 M) | ||||
| Working Capital | 8.16 M | ||||
About Cardio Diagnostics Performance
By examining Cardio Diagnostics' fundamental ratios, stakeholders can obtain critical insights into Cardio Diagnostics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cardio Diagnostics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.76) | (0.80) | |
| Return On Capital Employed | (0.75) | (0.79) | |
| Return On Assets | (0.91) | (0.95) | |
| Return On Equity | (0.79) | (0.83) |
Things to note about Cardio Diagnostics performance evaluation
Checking the ongoing alerts about Cardio Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardio Diagnostics generated a negative expected return over the last 90 days | |
| Cardio Diagnostics has high historical volatility and very poor performance | |
| Cardio Diagnostics may become a speculative penny stock | |
| Cardio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.89 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 15.78 K. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (4.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from newswire.com: Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to 38 Million |
- Analyzing Cardio Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardio Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Cardio Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardio Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardio Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardio Diagnostics' stock. These opinions can provide insight into Cardio Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Will Biotechnology sector continue expanding? Could Cardio diversify its offerings? Factors like these will boost the valuation of Cardio Diagnostics. Projected growth potential of Cardio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cardio Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.91) | Revenue Per Share | Quarterly Revenue Growth (0.57) | Return On Assets | Return On Equity |
Cardio Diagnostics's market price often diverges from its book value, the accounting figure shown on Cardio's balance sheet. Smart investors calculate Cardio Diagnostics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Cardio Diagnostics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cardio Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardio Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.